Endpoints News 生物医药· Max Gelman·· 6 天前AI 评分37
Windward Bio以1.75亿美元在纳斯达克上市,另获赛诺菲5000万美元
Windward Bio hits Nasdaq with $175M IPO, plus another $50M from Sanofi
AI 导读
Windward Bio以1.75亿美元IPO登陆纳斯达克,同时获得赛诺菲(Sanofi)5000万美元投资。该公司是一家专注于开发呼吸系统疾病治疗药物的生物技术公司。
正文
Windward Bio, a biotech developing drugs for respiratory diseases, made its public debut after putting together $175 million in its IPO.
The company began trading …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news